Use

This test is useful for establishing a diagnosis of plasma cell proliferative disorders, including multiple myeloma and other related conditions. It provides prognostic information for newly diagnosed multiple myeloma, assesses the response to therapy, and detects disease relapse and progression in treated patients. It determines the plasma cell DNA content and proliferation to provide valuable insights into the disease's clinical progression and aggressiveness.